Anne runs Brabant Advanced Materials, a specialty chemicals SME in Eindhoven. Here's her week.
Every Chainge user starts with a profile. The pipeline runs it through a diagnostic, then against the week's signals. What comes out isn't commentary, it's a cascade that lands in a sector you actually own.
research preview · Anne is a canonical fixture, not a live customer. The flow below is real; the contact path is a direct conversation with Niels, not a signup form.
What Chainge saw across Europe this week.
Three live moves: Europe stacked three trade tools to pressure the US, German industry could break the coalition, and Bulgaria's new pro-Moscow PM could quietly slow Europe's exit from Russian nuclear fuel.
Europe is executing a coordinated sovereignty play across trade, procurement, and energy simultaneously, using regulatory stacking (CBAM + IPI + FSR) as leverage in US negotiations while shoring up or fracturing critical infrastructure dependencies in its eastern flank. The most actionable thread is the FSR/IPI procurement doctrine: EU-domiciled cloud and AI vendors have a narrow, time-bounded window before Q2 2026 to position themselves as compliant "European Preference" suppliers on high-value public-sector contracts. The Mittelstand signal to watch is whether German industrial lobbies break publicly with Brussels on IPI activation: if BDI and VDMA oppose it, the entire tripartite squeeze loses its domestic political coalition and US negotiators gain room to fragment EU unity. The biggest open question is Bulgaria: Radev's durability as a Moscow-aligned actor inside NATO creates a potential veto point on VVER diversification timelines that neither Westinghouse's commercial roadmap nor EU energy-security planning has priced in.
read the full briefing →Anne filled this in via our profile prompt, which she ran in her own AI session. The fields below are an excerpt; the full schema runs to twelve dimensions.
company: brabant advanced materials BV
description: specialty chemicals SME, eindhoven (NL)
~€45M revenue, ~95 staff
product_families:
- high-purity rare-earth catalysts (REC, ~35%)
- electronic-grade silane intermediates (eSil, ~25%)
- NdPr concentrate for magnetic materials (~20%)
- specialty coating formulations (~15%)
- custom-synthesis toll services (~5%)
regulatory_regimes:
- REACH (applies)
- CLP (applies)
- CBAM (uncertain, see unknown_or_uncertain)
- CSRD (from FY2026, threshold-dependent)
- + Dutch ARBO / Seveso III, EU GDPR
currency_exposure:
- revenue: EUR
- cost: EUR + USD + CNY (mismatch on rare-earth feedstocks)
customer_geography: DE / NL / BE / LU / AT
unknown_or_uncertain:
- upstream mine/refiner provenance of NdPr concentrate
- exposure to Russian gas pricing via ammonia + ethylene-glycol
- whether eSil falls under any specialty-chemicals CBAM extensionProfile contributors get a discount tier. The richer your profile, the sharper your chains.
The diagnostic doesn't store the profile, it interrogates it.
inferred_persona: operator
checks_run: 5 / 5
items_surfaced: 11
flagged for review:
CBAM applicability Finished rare-earth oxides NOT in scope under
CELEX 2023/956 (cement, iron/steel, aluminium,
fertilisers, hydrogen, electricity).
BUT ammonia inputs on the eSil line ARE
covered under CN 2814.
Two reads, one product line.
CRMA exposure Not in profile. Applies. Reg 2024/1252 covers
downstream processors of Nd, Pr, Ce, La under
the Strategic Raw Materials list.
Action required.
CNY exposure NdPr concentrate spot purchases unhedged.
~20% of revenue. Asymmetric FX risk vs EUR
revenue, compounded by China REE export controls.
regulatory_confidence:
medium. Specific regs named by CELEX from training data.
EUR-Lex live lookup unavailable; verify against consolidated texts.
confirmed_at: 2026-05-13The diagnostic asks what the profile didn't answer. Then it asks whether the answers it inferred hold up.
what Anne sees that the market doesn'tThe real threat isn't US tariffs. It's whether German industry breaks the EU's trade coalition.
Most of the conversation about "European Preference" assumes the EU is one block pushing back on the US. The chain that actually binds Anne runs through German industry. CBAM input costs hit her ammonia the same way they hit a German mid-sized factory. If the US retaliates with export-control friction, both get hit. Whether Berlin blocks the EU's harshest moves depends on whether German industrial lobbies break the trade coalition first. That flip is the inflection point.
Starting January 2026, the EU charges a carbon tax on US steel, aluminium, fertiliser and cement imports.
CBAM enters definitive phase Jan 2026, embedding carbon costs on US steel, aluminium, fertiliser, cement imports. The tripartite stack (CBAM + IPI + FSR) is operational, not theoretical.
The carbon tax hits the EU's own factories harder than the US exporters it targets. For Anne, the tax lands on her ammonia inputs, not her finished products.
Input-cost pass-through hits EU downstream manufacturers harder than the US exporters it nominally targets. Dutch and German specialty chemicals, machine-tool, and automotive-supplier margins compress. For Brabant Advanced Materials specifically, the binding cost is ammonia under CBAM CN 2814, not the finished rare-earth oxides themselves.
The US doesn't fight back with tariffs. It restricts European access to AI chips and exports of dual-use machinery.
US retaliates not with goods tariffs but with services and export-control friction: tightened EAR licensing on GPU access, expanded Entity List scrutiny, selective ITAR pressure on dual-use machine tools. Flagged as a blind spot by both lenses.
German mid-sized manufacturers, squeezed on both sides, start lobbying Berlin to de-escalate the trade fight.
BDI and VDMA flip posture. Facing CBAM input costs at home AND US export-control friction on outbound shipments, the Mittelstand owner-operator cohort shifts from supporting "European Preference" to lobbying Berlin for de-escalation.
Berlin succeeds in blocking the worst of the EU's escalation. Anne is protected from US export-control backlash, but stuck with carbon-tax costs on her ammonia.
Germany assembles a Council qualified-majority blocking coalition. IPI activation against the US is delayed or diluted. CBAM and FSR enforcement persist. EU industrial firms across the Dutch-German corridor, including Brabant Advanced Materials, avoid the worst of US retaliation but inherit durable CBAM input-cost overhang.
Terminal node: Anne keeps her US-facing customer relationships and her GPU access, but eats CBAM compression on the ammonia inputs she'd flagged as uncertain. The Mittelstand lobby fight is what keeps the worse outcome off the table. The diagnostic caught CRMA on the way.
This was W19. The same exposure shape got hit again.
Anne's profile is a fixture. The chains crossing it are not. In the two weeks after W19, the same Brabant exposure shape got crossed by two new chains from different upstream pressures.
-
Trump-Xi summit ring-fences REE access to US buyers, with no multilateral hook to the EU. W20 · 2026-05-11
NdPr supply structurally tightens for European processors. CRMA Strategic Project relief lags by 12-18 months. Same Brabant exposure shape, different upstream pressure: input-cost shock instead of trade-tools shock. The diagnostic's CRMA flag from W19 carries forward and now sets up the W20 inflection.
-
Bilateral US-China rare-earth deal extends the pattern. EU consignees stay constrained. W21 · 2026-05-18
The following week the bilateral US-China rare-earth understanding formalizes. EU consignees remain under the 2023 Chinese export-licensing regime. Two-sided squeeze on the same Eindhoven house: input-cost rise on the rare-earth lines, German Tier-1 OEMs resist passthrough. The non-obvious turn is the second-order opportunity: a 2026-2027 commercial window opens for SMEs that can document non-Chinese provenance on their NdPr and REC lines.